Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder

George I. Papakostas, Timothy Petersen, Megan E. Hughes, Andrew A. Nierenberg, Jonathan E. Alpert, Maurizio Fava

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The purpose of this study was to examine the relationship between the degree of anxiety or somatic symptoms present before treatment with the subsequent diagnosis of treatment-related adverse events (TRAEs) in patients with major depressive disorder (MDD) enrolled in an 8-week open trial of fluoxetine (20 mg). Baseline symptom questionnaires (SQ) were completed by 170 MDD patients enrolled in the trial. We then tested whether pre-treatment scores for anxiety and somatic symptoms predicted (1) whether patients were subsequently diagnosed with TRAEs; (2) whether they were subsequently diagnosed with moderate or severe TRAEs; or (3) whether a greater number of TRAEs were diagnosed during the trial. We found that depressed patients who presented with prominent somatic symptoms were significantly more likely to report at least one moderate or severe side effect during the course of treatment, but not more likely to report a greater number of side effects. Pre-treatment anxiety was not related to the development of side effects.

Original languageEnglish (US)
Pages (from-to)287-290
Number of pages4
JournalPsychiatry Research
Volume126
Issue number3
DOIs
StatePublished - May 30 2004
Externally publishedYes

Fingerprint

Major Depressive Disorder
Anxiety
Therapeutics
Medically Unexplained Symptoms
Fluoxetine

Keywords

  • Drug trial
  • Fluoxetine
  • Major depression
  • Side effects

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder. / Papakostas, George I.; Petersen, Timothy; Hughes, Megan E.; Nierenberg, Andrew A.; Alpert, Jonathan E.; Fava, Maurizio.

In: Psychiatry Research, Vol. 126, No. 3, 30.05.2004, p. 287-290.

Research output: Contribution to journalArticle

Papakostas, George I. ; Petersen, Timothy ; Hughes, Megan E. ; Nierenberg, Andrew A. ; Alpert, Jonathan E. ; Fava, Maurizio. / Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder. In: Psychiatry Research. 2004 ; Vol. 126, No. 3. pp. 287-290.
@article{639c1e84a4174efb9433a5c6ebc84c4c,
title = "Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder",
abstract = "The purpose of this study was to examine the relationship between the degree of anxiety or somatic symptoms present before treatment with the subsequent diagnosis of treatment-related adverse events (TRAEs) in patients with major depressive disorder (MDD) enrolled in an 8-week open trial of fluoxetine (20 mg). Baseline symptom questionnaires (SQ) were completed by 170 MDD patients enrolled in the trial. We then tested whether pre-treatment scores for anxiety and somatic symptoms predicted (1) whether patients were subsequently diagnosed with TRAEs; (2) whether they were subsequently diagnosed with moderate or severe TRAEs; or (3) whether a greater number of TRAEs were diagnosed during the trial. We found that depressed patients who presented with prominent somatic symptoms were significantly more likely to report at least one moderate or severe side effect during the course of treatment, but not more likely to report a greater number of side effects. Pre-treatment anxiety was not related to the development of side effects.",
keywords = "Drug trial, Fluoxetine, Major depression, Side effects",
author = "Papakostas, {George I.} and Timothy Petersen and Hughes, {Megan E.} and Nierenberg, {Andrew A.} and Alpert, {Jonathan E.} and Maurizio Fava",
year = "2004",
month = "5",
day = "30",
doi = "10.1016/j.psychres.2004.02.007",
language = "English (US)",
volume = "126",
pages = "287--290",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder

AU - Papakostas, George I.

AU - Petersen, Timothy

AU - Hughes, Megan E.

AU - Nierenberg, Andrew A.

AU - Alpert, Jonathan E.

AU - Fava, Maurizio

PY - 2004/5/30

Y1 - 2004/5/30

N2 - The purpose of this study was to examine the relationship between the degree of anxiety or somatic symptoms present before treatment with the subsequent diagnosis of treatment-related adverse events (TRAEs) in patients with major depressive disorder (MDD) enrolled in an 8-week open trial of fluoxetine (20 mg). Baseline symptom questionnaires (SQ) were completed by 170 MDD patients enrolled in the trial. We then tested whether pre-treatment scores for anxiety and somatic symptoms predicted (1) whether patients were subsequently diagnosed with TRAEs; (2) whether they were subsequently diagnosed with moderate or severe TRAEs; or (3) whether a greater number of TRAEs were diagnosed during the trial. We found that depressed patients who presented with prominent somatic symptoms were significantly more likely to report at least one moderate or severe side effect during the course of treatment, but not more likely to report a greater number of side effects. Pre-treatment anxiety was not related to the development of side effects.

AB - The purpose of this study was to examine the relationship between the degree of anxiety or somatic symptoms present before treatment with the subsequent diagnosis of treatment-related adverse events (TRAEs) in patients with major depressive disorder (MDD) enrolled in an 8-week open trial of fluoxetine (20 mg). Baseline symptom questionnaires (SQ) were completed by 170 MDD patients enrolled in the trial. We then tested whether pre-treatment scores for anxiety and somatic symptoms predicted (1) whether patients were subsequently diagnosed with TRAEs; (2) whether they were subsequently diagnosed with moderate or severe TRAEs; or (3) whether a greater number of TRAEs were diagnosed during the trial. We found that depressed patients who presented with prominent somatic symptoms were significantly more likely to report at least one moderate or severe side effect during the course of treatment, but not more likely to report a greater number of side effects. Pre-treatment anxiety was not related to the development of side effects.

KW - Drug trial

KW - Fluoxetine

KW - Major depression

KW - Side effects

UR - http://www.scopus.com/inward/record.url?scp=2442591791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442591791&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2004.02.007

DO - 10.1016/j.psychres.2004.02.007

M3 - Article

VL - 126

SP - 287

EP - 290

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 3

ER -